BBWI
Bath & Body Works, Inc.
BBWI has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BBWI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
BBWI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BBWI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.6x | $21.08 | — |
| Cheap | 6.8x | $25.98 | +23% |
| Forward | 7.9x | $21.08 | — |
| Fair | 9.6x | $36.49 | +73% |
| Expensive | 13x | $49.09 | +133% |
Historical ranges are pointers, not guarantees.
BBWI's PE is in its cheap range at 5.5x. On analysts' estimates for next year's earnings, today's price would be 7.9x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BBWI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Growth | |
| Stable | |
| Stable | |
| Moderate | |
| High |
Analysts expect BBWI's earnings to grow, with its revenue and profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BBWI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.65 | -30% |
| Q3 2026 | $3.80 | +14% |
| Q2 2026 | $3.52 | -5.4% |
| Q1 2026 | $3.11 | -14% |
| Q4 2025 | $3.22 | -21% |
| Q3 2025 | $3.34 | -19% |
| Q2 2025 | $3.72 | -3.9% |
| Q1 2025 | $3.61 | -6% |
| Q4 2024 | $4.09 | +28% |
BBWI has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BBWI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -2.3% |
| Q2 2026 | $1.4B | -3.2% |
| Q1 2026 | $2.7B | -2.3% |
| Q4 2025 | $1.6B | -1% |
| Q3 2025 | $1.5B | +1.5% |
| Q2 2025 | $1.4B | +2.9% |
| Q1 2025 | $2.8B | -4.3% |
| Q4 2024 | $1.6B | +3.1% |
BBWI's revenue fell from its 2021 peak and has held roughly level since: $1.5B last quarter, down 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.1 points |
| Q2 2026 | 17% | +2.1 points |
| Q1 2026 | 22% | -2.3 points |
| Q4 2025 | 10% | -3.4 points |
| Q3 2025 | 10% | -1.8 points |
| Q2 2025 | 15% | +1.2 points |
| Q1 2025 | 24% | +0.4 points |
| Q4 2024 | 14% | -0.6 points |
BBWI has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BBWI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BBWI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $23M | +$122M |
| Q2 2026 | $195M | +29% |
| Q1 2026 | $814M | -9.1% |
| Q4 2025 | -$1M | +$163M |
| Q3 2025 | -$99M | +$2M |
| Q2 2025 | $151M | +403% |
| Q1 2025 | $895M | +1.9% |
| Q4 2024 | -$164M | -$43M |
BBWI has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BBWI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -4.3% | -9M shares |
| 3 years | -12% | -27M shares |
| 5 years | -28% | -78M shares |
| Available history | -27% | -74M shares |
BBWI has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $57M |
| Q4 2025 | $90M |
| Q3 2025 | $118M |
| Q2 2025 | $136M |
| Q1 2025 | $52M |
| Q4 2024 | $101M |
BBWI spent $147M buying back its own shares over the past year, down 64% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BBWI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 2.0x | Moderate |
| Q1 2026 | 2.1x | Moderate |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 2.6x | Moderate |
BBWI's net debt is about 1.9 years of its operating earnings (EBITDA), down from 2.3 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BBWI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 76.4 | Neutral |
BBWI's weekly RSI is 54 (neutral) and its Stochastic is 76 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BBWI PE vs Consumer Cyclical Sector
| Metric | BBWI | Sector median | Relative |
|---|---|---|---|
| PE | 5.6x | 18x | 69% below |
| PE % | 5 | 47 | 42 pts below |
BBWI is trading at 5.5x earnings, a 69% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BBWI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.5 | 8% above |
| 20 week MA | $19.7 | 7.2% above |
| 50 week MA | $20.1 | 5% above |
| 100 week MA | $25.0 | 16% below |
| 200 week MA | $31.5 | 33% below |
BBWI has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BBWI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.7 | $31.5 | +114% |
| 2021 | $31.5 | $69.5 | +121% |
| 2022 | $69.5 | $41.9 | -40% |
| 2023 | $41.9 | $43.2 | +2.9% |
| 2024 | $43.2 | $38.2 | -12% |
| 2025 | $38.2 | $19.8 | -48% |
| 2026 YTD | $19.8 | $21.1 | +6.5% |
BBWI has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.